Skip to main content

Abstract

Dopamine is the dominant catecholamine neurotransmitter in the mammalian brain. It is found throughout the entire central nervous system, but is predominant in the nigrostriatal, mesolimbic, and tuberoinfundibular tracts (Creese et al., 1983). Dopamine exerts its effects through binding to two types of receptor, the D1 and D2 receptors (Kebabian and Calne, 1979). Binding of dopamine to its receptors induces several second messenger systems, most importantly affecting cAMP levels (Vallar and Meldolesi, 1989). Activation of the D1 receptor stimulates adenylyl cyclase activity which results in an increase in intracellular cAMP levels while binding of dopamine to the D2 receptor inhibits the cyclase activity (Caron et al., 1978).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Albert PR, Neve KA, Bunzow JR, Civelli O (1990): Biological activity of the rat D2 dopamine receptor cDNA expressed in GH4C1 rat pituitary cells. J Biol Chem 265: 2078–2104

    Google Scholar 

  • Bunzow JR, Van Tol HHM, Grandy DK, Albert P, Salon J, Christie M, Machida CA, Neve KA, Civelli O (1988): Cloning and expression of a rat D2 dopamine receptor cDNA. 336: 783–787

    Google Scholar 

  • Byerley W, Mellon C, Holik J, Lubbers A, Leppert M, O’Connell P, Reimherr F, Grosser B, Wender P, Bunzow J, Grandy D, Civelli O, Lalouel JM, White R, Litt M (1989): Molecular genetics studies using the D2 dopamine receptor. APA New Res Abstr

    Google Scholar 

  • Carlsson A (1975): Dopaminergic autoreceptors. In: Chemical Tools in Catecholamine Research II: Regulation of Catecholamine Turnover, Almgren O, Carlsson A, Engel J, Amsterdam: North-Holland Publishing Company, pp 219–225

    Google Scholar 

  • Caron MG, Beaulieu M, Raymond V, Gagne B, Drouin J, Lefkowitz J, Labrie F (1978): Dopaminergic receptors in the anterior pituitary gland. J Biol Chem 253: 2244–2253

    Google Scholar 

  • Creese I, Sibley DR, Hamblin MW, Leff SE (1983): The classification of dopamine receptors: Relationship to radioligand binding. Annu Rev Neurosci 6: 43–71

    Google Scholar 

  • Dixon RAF, Koblika BK, Strader DJ, Benovic JL, Dolhman HG, Frielle T, Bolanowski M, Bennett C, Rands E, Diehl R, Mumford R, Slater E, Sigal I, Caron M, Lefkowitz R, Strader C (1986): Cloning of the gene and cDNA for mammalian Ăź-adrenergic receptor and homology with rhodopsin. Nature 321: 75–79

    Article  Google Scholar 

  • Dixon RAF, Sigal IS, Candelore MR, Register RB, Scattergood W, Rands E, Strader CD (1987): Structural features required for ligand binding to the Ăź-adrenergic receptor. EMBO J 6: 3269–3275

    Google Scholar 

  • Dohlman HG, Caron MG, Lefkowitz RJ (1987): A family of receptors coupled to guanine nucleotide regulatory proteins. Biochemistry 26: 2657–2664

    Article  Google Scholar 

  • Gelernter J, Pakstis AJ, Chappell P, Kurlan R, Grandy DK, Bunzow J, Retief AE, Litt M, Civelli O, Kidd KK (1989): Tourette syndrome is not linked to D2 dopamine receptor. Am Psych Assoc Abstr

    Google Scholar 

  • Grandy DK, Litt M, Allen L, Bunzow JR, Marchionni M, Makam H, Reed L, Magenis RE, Civelli O (1989): The human dopamine D2 receptor gene is located on chromosome 11 at q22–q23 and identifies a TaqI RFLP. Am J Hum Genet 45: 778–785

    Google Scholar 

  • Hall ZA (1987): Three of a kind: The Ăź-adrenergic receptor, the muscarinic acetylcholine receptor, and rhodopsin. Trends Neuro Sci 10: 99–100

    Article  Google Scholar 

  • Hess EJ, Creese I (1987): Biochemical characterization of dopamine receptors. In: Receptor Biochemistry and Methodology, Creese I, Fraser CM, eds. New York: Liss, p 27

    Google Scholar 

  • Isenberg KE, Burgess AK, Litt M, Grandy D, Civelli O, Devor EJ (1989): Genetic linkage study of a D2-dopamine receptor and flanking probes spanning 1 Iq22–q23 in Tourette syndrome. Am Soc Hum Genet Abstr

    Google Scholar 

  • Julius D, MacDermott AB, Axel R, Jessell TM (1988): Molecular characterization of a functional cDNA encoding the serotonin lc receptor. Science 241: 558–564

    Article  Google Scholar 

  • Kebabian JW, Calne DB (1979): Multiple receptors for dopamine. Nature 277: 93–96

    Article  Google Scholar 

  • Masu Y, Nakayama K, Tamaki H, Harada Y, Kuno M, Nakanishi S (1987): cDNA cloning of bovine substance-K receptor through oocyte expression system. Nature 329: 836–838

    Google Scholar 

  • Meador-Woodruff JH, Mansour A, Bunzow JR, Van Tol HHM, Watson SJ, Civelli O (1989): Distribution of D2 dopamine receptor mRNA in rat brain. Proc Natl Acad Sci USA 86: 7625–7628

    Article  Google Scholar 

  • Moises HW, Gelernter J, Grandy DK, Giuffra LA, Kidd JR, Pakstis AJ, Bunzow J, Sjögren B, Wettenberg L, Kennedy JL, Litt M, Civelli O, Kidd KK, Cavalli-Sforza LL (1989): Exclusion of the D2-dopamine receptor gene as candidate gene for schizophrenia in a large pedigree from Sweden. Psych genet Conf Abstr

    Google Scholar 

  • Neve KA, Henningsen RA, Bunzow JR, Civelli O (1989): Functional characterization of a rat dopamine D2 receptor cDNA expressed in a mammalian cell line. Mol Pharmacol 36: 446–451

    Google Scholar 

  • O’Dowd BF, Hnatowich M, Caron MG, Lefkowitz RJ, Bouvier, M (1989): Palmitoylation of the human Ăź2-adrenergic receptor. J Biol Chem 264: 7564–7569

    Google Scholar 

  • Seeman P (1987): Dopamine receptors and the dopamine hypothesis of schizophrenia. Synapse 1: 133–152

    Article  Google Scholar 

  • Seeman P, Lee T (1975): Antipsychotic drugs: Direct correlation between clinical potency and presynaptic action on dopamine neurons. Science 188: 1217–1219

    Google Scholar 

  • Seeman P, Lee T, Chau-Wong M, Wong K (1976): Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature 261: 717–719

    Article  Google Scholar 

  • Senogles SE, Amlaiky N, Falardeau P, Caron MG (1988): Purification and characterization of the D2-dopamine receptor from bovine anterior pituitary. J Biol Chem 263: 18996–19002

    Google Scholar 

  • Stevens CF (1987): Channel families in the brain. Nature 328: 198–199

    Article  Google Scholar 

  • Strader CD, Sigal IS, Candelore MR, Rands E, Hill WS, Dixon RAF (1988): Conserved aspartic acid residues 79 and 113 of the Ăź-adrenergic receptor have different roles in receptor function. J Biol Chem 263: 10267–10271

    Google Scholar 

  • Strader CD, Sigal IS, Register RB, Candelore MR, Rands E, Dixon RAF (1987): Identification of residues required for ligand binding to the Ăź-adrenergic receptor. Proc Natl Acad Sci USA 84: 4384–4388

    Article  Google Scholar 

  • Vallar L, Meldolesi J (1989): Mechanisms of signal transduction at the dopamine D2 receptor. Trends Pharmacol Sci 10: 74–77

    Article  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1992 Birkhäuser Boston

About this chapter

Cite this chapter

Civelli, O., Bunzow, J., Albert, P., Van Tol, H.H.M., Grandy, D. (1992). The Dopamine D2 Receptor. In: Brann, M.R. (eds) Molecular Biology of G-Protein-Coupled Receptors. Applications of Molecular Genetics to Pharmacology. Birkhäuser Boston. https://doi.org/10.1007/978-1-4684-6772-7_7

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-6772-7_7

  • Publisher Name: Birkhäuser Boston

  • Print ISBN: 978-1-4684-6774-1

  • Online ISBN: 978-1-4684-6772-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics